Press release
Anti-Asthmatics And COPD Drugs Market Overview Report, Revenue, Industry Szie, Huge Growth, Global Opportunities And Forecast 2023-2032: Novartis AG, Merck & Co., GlaxoSmithKline, Boehringer Ingelheim Gmbh
Anti-Asthmatics And COPD Drugs Market
As per the anti-asthmatics and copd drugs market report by The Business Research Company, modifiable risk factors including smoking, lack of physical exercise, and unhealthy eating habits drive the Asthma and COPD drugs market. Even though there is a decreasing trend in smoking prevalence globally, developing countries such as China, India, Indonesia, and Nigeria among others have increasing smoking prevalence. For instance, the number of tobacco smokers is set to increase by 24 million in Indonesia and by 7 million in Nigeria by 2025, and more than 40% of global cigarette consumption is concentrated in China. Consumption of fats including saturated fatty acids which is a risk factor for Asthma and COPD is more in high-income countries including the USA and Europe.
The global anti-asthmatics and copd drugs market size will grow from $88.20 billion in 2022 to $94.10 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The global anti-asthmatics and copd drugs market size is expected to grow to $117.36 billion in 2027 at a CAGR of 5.7%.
Read More On The Anti-Asthmatics And COPD Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-global-market-report
Major competitors in the include Novartis AG, Merck & Co., GlaxoSmithKline, Boehringer Ingelheim Gmbh, AstraZeneca, Roche, Teva Pharmaceutical, Vectura, Pfizer and Abbott.
The anti-asthmatics and COPD drugs market is segmented -
• By Type: Anti-histamine Drugs, long-acting ß2-agonists (LABA), Inhaled corticosteriods, Short-acting muscarinic receptor antagonists (SAMAs), Other Anti-Asthmatics And COPD Drugs (including Combinations)
• By Drug Class: Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs
• By End User: Asthma Patients, COPD Patients
• By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Anti-Asthmatics And COPD Drugs market.
Request A Free Sample Of The Anti-Asthmatics And COPD Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3802&type=smp
The anti-asthmatic and chronic obstructive pulmonary disease market consists of corticosteroid, bronchodilator, fluticasone and salmeterol. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The Table Of Content For The Anti-Asthmatics And COPD Drugs Market Include:
1. Executive Summary
2. Anti-Asthmatics And COPD Drugs Market Characteristics
3. Anti-Asthmatics And COPD Drugs Market Trends And Strategies
4. Anti-Asthmatics And COPD Drugs Market - Macro Economic Scenario
5. Anti-Asthmatics And COPD Drugs Market Size And Growth
6. Anti-Asthmatics And COPD Drugs Market Segmentation
…………
27. Anti-Asthmatics And COPD Drugs Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market
29. Anti-Asthmatics And COPD Drugs Market Future Outlook And Potential Analysis
30. Appendix
The "Global Anti-Asthmatics And COPD Drugs Market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Asthmatics And COPD Drugs Market Overview Report, Revenue, Industry Szie, Huge Growth, Global Opportunities And Forecast 2023-2032: Novartis AG, Merck & Co., GlaxoSmithKline, Boehringer Ingelheim Gmbh here
News-ID: 2883069 • Views: …
More Releases from The Business research company
Hospital Asset Management Systems Market: Global Size, Share, Growth, Trends, An …
The hospital asset management systems market size has grown exponentially in recent years. It will grow from $21.85 billion in 2023 to $27.1 billion in 2024 at a compound annual growth rate (CAGR) of 24.0%. The growth in the historic period can be attributed to regulatory compliance, cost reduction initiatives, rising healthcare costs, patient safety, inventory control.
The hospital asset management systems market size is expected to…
Direct Reduced Iron Global Market Analysis, Trends, Growth, Research And Forecas …
The direct reduced iron market size has grown strongly in recent years. It will grow from $28.98 billion in 2023 to $31.8 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to raw material availability, steel industry dynamics, energy efficiency concerns, environmental regulations, cost competitiveness.
The direct reduced iron market size is expected to see strong growth…
Vitamin And Mineral Premixes Market 2024 Report By Key Companies, Regional Analy …
The vitamin and mineral premixes market size has grown strongly in recent years. It will grow from $8.36 billion in 2023 to $8.92 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to nutritional deficiency awareness, rise in functional foods, global population growth, expansion of the food and beverage industry, government initiatives for fortification.
The vitamin and…
Transcatheter Aortic Valve Replacement Trends, Top Companies, Share, Growth And …
The transcatheter aortic valve replacement market size has grown rapidly in recent years. It will grow from $4.63 billion in 2023 to $5.32 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising prevalence of aortic regurgitation, rising prevalence of cardiovascular diseases, increasing patient preference for minimally invasive therapies, global expansion of tavr procedures, favorable…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
